Annovis Bio Inc

ANVS

Company Profile

  • Business description

    Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

  • Contact

    101 Lindenwood Drive
    Suite 225
    MalvernPA19355
    USA

    T: +1 484 875-3192

    https://www.annovisbio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    6

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,775.004.400.05%
CAC 407,742.2457.560.75%
DAX 4023,699.12182.890.78%
Dow JONES (US)42,595.94398.150.94%
FTSE 1008,875.2224.590.28%
HKSE24,060.99168.430.70%
NASDAQ19,716.43309.601.60%
Nikkei 22538,311.33477.081.26%
NZX 50 Index12,690.13137.261.09%
S&P 5006,040.6263.651.06%
S&P/ASX 2008,548.401.000.01%
SSE Composite Index3,388.7311.730.35%

Market Movers